Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jewell

Showing results (501-510 of 529) with videos related to

Pageof 53
Sort By:
Journal of Medicinal Chemistry|May 16, 2009
Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4Linus S Lin, Thomas Lanza, James P Jewell, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitorsJason D Katz, Andrew Haidle, Kaleen K Childers, et al.
Gates Open Research|April 22, 2020
Establishment of <i>w</i>Mel <i>Wolbachia</i> in <i>Aedes aegypti</i> mosquitoes and reduction of local dengue transmission in Cairns and surrounding locations in northern Queensland, AustraliaPeter A Ryan, Andrew P Turley, Geoff Wilson, et al.
Gut|December 25, 2012
Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European ProjectIsabelle Cleynen, Juan R González, Carolina Figueroa, et al.
Wellcome Open Research|May 31, 2024
Drivers of Resistance in Uganda and Malawi (DRUM): a protocol for the evaluation of One-Health drivers of Extended Spectrum Beta Lactamase (ESBL) resistance in Low-Middle Income Countries (LMICs)Derek Cocker, Melodie Sammarro, Kondwani Chidziwisano, et al.
F1000Research|December 15, 2021
The impact of city-wide deployment of <i>Wolbachia</i>-carrying mosquitoes on arboviral disease incidence in Medellín and Bello, Colombia: study protocol for an interrupted time-series analysis and a test-negative design studyIvan D Velez, Eduardo Santacruz, Simon C Kutcher, et al.
Molecular Cancer Therapeutics|December 4, 2025
Activity of direct KRAS(G12C) inhibitors in preclinical models of pediatric cancerHannah E Price, Stacey Stauffer, Hyun Lee, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityIyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.
The New England Journal of Medicine|June 9, 2021
Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of DengueAdi Utarini, Citra Indriani, Riris A Ahmad, et al.
Human Molecular Genetics|August 1, 1997
Linkage analysis of candidate regions for coeliac disease genesR S Houlston, I P Tomlinson, D Ford, et al.
Pageof 53

Showing results (501-510 of 529) with videos related to

Sort By:
Pageof 53
Journal of Medicinal Chemistry|May 16, 2009
Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4Linus S Lin, Thomas Lanza, James P Jewell, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2016
Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitorsJason D Katz, Andrew Haidle, Kaleen K Childers, et al.
Gates Open Research|April 22, 2020
Establishment of <i>w</i>Mel <i>Wolbachia</i> in <i>Aedes aegypti</i> mosquitoes and reduction of local dengue transmission in Cairns and surrounding locations in northern Queensland, AustraliaPeter A Ryan, Andrew P Turley, Geoff Wilson, et al.
Gut|December 25, 2012
Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European ProjectIsabelle Cleynen, Juan R González, Carolina Figueroa, et al.
Wellcome Open Research|May 31, 2024
Drivers of Resistance in Uganda and Malawi (DRUM): a protocol for the evaluation of One-Health drivers of Extended Spectrum Beta Lactamase (ESBL) resistance in Low-Middle Income Countries (LMICs)Derek Cocker, Melodie Sammarro, Kondwani Chidziwisano, et al.
F1000Research|December 15, 2021
The impact of city-wide deployment of <i>Wolbachia</i>-carrying mosquitoes on arboviral disease incidence in Medellín and Bello, Colombia: study protocol for an interrupted time-series analysis and a test-negative design studyIvan D Velez, Eduardo Santacruz, Simon C Kutcher, et al.
Molecular Cancer Therapeutics|December 4, 2025
Activity of direct KRAS(G12C) inhibitors in preclinical models of pediatric cancerHannah E Price, Stacey Stauffer, Hyun Lee, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityIyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.
The New England Journal of Medicine|June 9, 2021
Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of DengueAdi Utarini, Citra Indriani, Riris A Ahmad, et al.
Human Molecular Genetics|August 1, 1997
Linkage analysis of candidate regions for coeliac disease genesR S Houlston, I P Tomlinson, D Ford, et al.
Pageof 53